Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pidilizumab in metastatic melanoma
NCT01435369Phase 2Completed
- Sponsor
- Medivation
- Start
- Nov 2011
- Primary completion
- Aug 2013
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of pidilizumab in melanoma, sponsored by Medivation. Started Nov 2011; status: completed.
02
Drugs
pidilizumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01435369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01435369.